You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclin D1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)

Not yet recruiting
  • Multiple Myeloma
  • Bone marow biopsy and aspiration
  • biochemical and heamatological tests
  • (no location specified)
Aug 9, 2023

Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Mouth Neoplasms
  • Carcinoma, Squamous Cell
  • TPF group
  • +2 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 5, 2022

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Nice, Alpes-Maritimes, France
  • +10 more
Jan 16, 2023

Breast Cancer Trial in New York (Fulvestrant, Tamoxifen)

Terminated
Has Results
  • Breast Cancer
  • New York, New York
  • +2 more
Apr 27, 2021

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

Withdrawn
  • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
  • +3 more
  • (no location specified)
Oct 13, 2021

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
May 17, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Plexin D1 as a Potential Biomarker inPM/DM

    Not yet recruiting
    • Polymyositis
    • Dermatomyositis
    • plexinD1
    • (no location specified)
    Nov 25, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • CDK Inhibitor AT7519
    • +3 more
    • Washington, District of Columbia
    • +5 more
    Oct 18, 2022

    Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)

    Available
    • Pancreatic Cancer
    • +6 more
    • Santa Monica, California
      Sarcoma Oncology Research Center, LLC
    Jan 20, 2022

    D1 vs D2 Lymphadenectomy in Gastric Cancer

    Completed
    • Gastric Cancer
    • Lymphadenectomy type
    • (no location specified)
    Feb 22, 2022

    Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

    Recruiting
    • Recurrent Endometrial Carcinoma
    • +3 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Oct 28, 2021

    Non-melanoma Skin Cancer Trial in Birmingham (UAB30, Placebo)

    Recruiting
    • Non-melanoma Skin Cancer
    • Birmingham, Alabama
      UAB Dermatology
    Aug 30, 2022

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

    Completed
    Has Results
    • Breast Cancer
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 13, 2022

    Breast Cancer Trial (Ribociclib)

    No longer available
    • Breast Cancer
    • (no location specified)
    Feb 15, 2022

    Irritable Bowel Syndrome With Constipation Trial in Dijon (Probiotics mixture)

    Recruiting
    • Irritable Bowel Syndrome With Constipation
    • Probiotics mixture
    • Dijon, Bourgogne, France
      CEN Nutriment
    Mar 8, 2022

    Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

    Recruiting
    • Chondrosarcoma
    • +2 more
    • Jacksonville, Florida
    • +3 more
    Apr 4, 2022

    Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)

    Not yet recruiting
    • Cervical Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Aug 16, 2023

    Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Changchun, Jilin, China
      Jilin Cancer Hospital
    Jun 21, 2023

    Type 1 Diabetes Trial in Salt Lake City (FAMS-T1D, Digital resources for diabetes)

    Recruiting
    • Type 1 Diabetes
    • FAMS-T1D
    • Digital resources for diabetes
    • Salt Lake City, Utah
      University of Utah
    Apr 7, 2023